(Q33330996)

25 July 2017

title

Usefulness of cilostazol versus ticlopidine in coronary artery stenting (English)

1 reference

25 July 2017

Y Yoon

1

1 reference

25 July 2017

W H Shim

2

1 reference

25 July 2017

D H Lee

3

1 reference

25 July 2017

W B Pyun

4

1 reference

25 July 2017

I J Kim

5

1 reference

25 July 2017

Y Jang

6

1 reference

25 July 2017

S Y Cho

7

1 reference

25 July 2017

language of work or name

English

0 references

publication date

1 December 1999

1 reference

American Journal of Cardiology

25 July 2017

published in

1 reference

25 July 2017

volume

84

1 reference

25 July 2017

issue

12

1 reference

25 July 2017

page(s)

1375-1380

1 reference

A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900579-2

A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900579-2

Angiographic follow-up after placement of a self-expanding coronary-artery stent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900579-2

A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900579-2

A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900579-2

Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The full anticoagulation versus aspirin and ticlopidine (fantastic) study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900579-2

A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900579-2

The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900579-2

Fatal neutropenia and thrombocytopenia associated with ticlopidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900579-2

A randomized comparison of combined ticlopidine and aspirin therapy versus aspirin therapy alone after successful intravascular ultrasound-guided stent implantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900579-2

Prevention of ischemic stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900579-2

Neutropenia with ticlopidine plus aspirin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900579-2

Thrombotic thrombocytopenic purpura after stenting and ticlopidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900579-2

Thrombotic thrombocytopenic purpura associated with ticlopidine. A review of 60 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900579-2

Effects of cilostazol, a selective cAMP phosphodiesterase inhibitor on the contraction of vascular smooth muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900579-2

Use of cilostazol, a novel antiplatelet agent, in a post-Palmaz-Schatz stenting regimen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900579-2

A randomized trial of aspirin versus cilostazol therapy after successful coronary stent implantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900579-2

Effects of probucol and cilostazol alone and in combination on frequency of poststenting restenosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900579-2

Effects of cilostazol on late lumen loss after Palmaz-Schatz stent implantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900579-2

Pharmacology of ticlopidine: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900579-2

Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900579-2

Effect of Cilostazol, a Cyclic AMP Phosphodiesterase Inhibitor, on the Proliferation of Rat Aortic Smooth Muscle Cells in Culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900579-2

Effect of the novel antiplatelet agent cilostazol on plasma lipoproteins in patients with intermittent claudication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900579-2

10.1016/S0002-9149(99)00579-2

7 January 2021

Identifiers

DOI

1 reference

25 July 2017

1 reference